Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalMarket CapitalizationReturn on AssetsReturn on Capital EmployedReturn on Equity

Fulcrum Therapeutics (FULC) Gross Margin: 2020-2024

Historic Gross Margin for Fulcrum Therapeutics (FULC) over the last 4 years, with Jun 2024 value amounting to 100.00%.

  • Fulcrum Therapeutics' Gross Margin changed negligibly% to 100.00% in Q2 2024 from the same period last year, while for Jun 2024 it was 100.00%, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of 100.00% for FY2024, which is negligibly% changed negligibly from last year.
  • According to the latest figures from Q2 2024, Fulcrum Therapeutics' Gross Margin is 100.00%, which was down 0.00% from 100.00% recorded in Q4 2023.
  • Fulcrum Therapeutics' Gross Margin's 5-year high stood at 100.00% during Q1 2020, with a 5-year trough of 100.00% in Q1 2020.
  • Moreover, its 3-year median value for Gross Margin was 100.00% (2024), whereas its average is 100.00%.